Jessica Potts j.e.potts@keele.ac.uk
The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis
Potts, JE; Gray, L; Brady, E; Khunti, K; Davies, M; Bodicoat, D
Authors
L Gray
E Brady
K Khunti
M Davies
D Bodicoat
Abstract
Aims
To determine the effects of glucagon-like peptide-1 receptor agonists compared with placebo and other anti-diabetic agents on weight loss in overweight or obese patients with type 2 diabetes mellitus.
Methods
Electronic searches were conducted for randomised controlled trials that compared a glucagon-like peptide-1 receptor agonist therapy at a clinically relevant dose with a comparator treatment (other type 2 diabetes treatment or placebo) in adults with type 2 diabetes and a mean body mass index = 25kg/m2. Pair-wise meta-analyses and mixed treatment comparisons were conducted to examine the difference in weight change at six months between the glucagon-like peptide-1 receptor agonists and each comparator.
Results
In the mixed treatment comparison (27 trials), the glucagon-like peptide-1 receptor agonists were the most successful in terms of weight loss; exenatide 2mg/week: -1.62kg (95% CrI: -2.95kg, -0.30kg), exenatide 20µg: -1.37kg (95% CI: -222kg, -0.52kg), liraglutide 1.2mg: -1.01kg (95%CrI: -2.41kg, 0.38kg) and liraglutide 1.8mg: -1.51 kg (95% CI: -2.67kg, -0.37kg) compared with placebo. There were no differences between the GLP-1 receptor agonists in terms of weight loss.
Conclusions
This review provides evidence that glucagon-like peptide-1 receptor agonist therapies are associated with weight loss in overweight or obese patients with type 2 diabetes with no difference in weight loss seen between the different types of GLP-1 receptor agonists assessed.
Citation
Potts, J., Gray, L., Brady, E., Khunti, K., Davies, M., & Bodicoat, D. (2015). The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis. PloS one, https://doi.org/10.1371/journal.pone.0126769
Acceptance Date | Apr 7, 2015 |
---|---|
Publication Date | Jun 29, 2015 |
Journal | PloS one |
Print ISSN | 1932-6203 |
Publisher | Public Library of Science |
DOI | https://doi.org/10.1371/journal.pone.0126769 |
Publisher URL | https://doi.org/10.1371/journal.pone.0126769 |
Files
J Potts - The effect of glucagon-like peptide 1 receptor....PDF
(494 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Hypertensive disorders of pregnancy and impact on in-hospital cardio-obstetric outcomes
(2020)
Presentation / Conference
In-hospital Upper Gastrointestinal Bleeding Following Percutaneous Coronary Intervention
(2020)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search